[1] Braunwald E. Heart failure [J]. JACC Heart Failure, 2013, 1(1): 1-20.
[2] Daniels L B, Maisel A S. Natriuretic peptides [J]. Journal of the American College of Cardiology, 2007, 50(25): 2357-2368.
[3] Maisel A, Mueller C, Adams K F, et al. State of the art: using natriuretic peptide levels in clinical practice [J]. European Journal of Heart Failure, 2008, 10(9): 824-839.
[4] Tang Y D, Katz S D. Anemia in chronic heart failure: prevalence, etiology, clinical correlates, and treatment options [J]. Circulation, 2006, 113(20): 2454-2461.
[5] Felker G M, Adams K F, Gattis W A, Jr., et al. Anemia as a risk factor and therapeutic target in heart failure [J]. Journal of the American College of Cardiology, 2004, 44(5): 959-966.
[6] Kalantar-Zadeh K, Anker S D, Horwich T B, et al. Nutritional and anti-inflammatory interventions in chronic heart failure [J]. American Journal of Cardiology, 2008, 101(11A): 89E-
103E.
[7] He W, Jia J, Chen J, et al. Comparison of prognostic value of red cell distribution width and NT-proBNP for short-term clinical outcomes inacute heart failure patients [J]. International Heart Journal, 2014, 55(1): 58-64.
[8] Darze E S, Latado A L, Guimaraes A G, et al. Acute pulmonary embolism is an independent predictor of adverse events in severe decompensated heart failure patients [J]. Chest, 2007, 131(6): 1838-1843.
[9] Ng T M, Tsai F, Khatri N, et al. Venous thromboembolism in hospitalized patients with heart failure: incidence, prognosis, and prevention [J]. Circulation Heart Failure, 2010, 3(1): 165-173.
[10] 李珊珊, 高蓉蓉, 张海锋, 等. sST2和半乳糖凝集素3对急性心力衰竭短期预后的预测价值[J]. 江苏医药, 2016, 42(4): 402-404. |